(Q41178500)

27 September 2017

title

Evidence against important catecholamine compensation for absent glucagon counterregulation (English)

1 reference

27 September 2017

1 reference

8

Gerich JE

1 reference

27 September 2017

De Feo P

1

1 reference

27 September 2017

Perriello G

2

1 reference

27 September 2017

Torlone E

3

1 reference

27 September 2017

Fanelli C

4

1 reference

27 September 2017

Ventura MM

5

1 reference

27 September 2017

Santeusanio F

6

1 reference

27 September 2017

Brunetti P

7

1 reference

27 September 2017

Bolli GB

9

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

American Journal of Physiology

27 September 2017

published in

1 reference

27 September 2017

volume

260

1 reference

27 September 2017

issue

2 Pt 1

1 reference

27 September 2017

page(s)

E203-12

1 reference

Hyperglucagonemia and insulin-mediated glucose metabolism

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Role of hepatic autoregulation in defense against hypoglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Characterization of seven C-peptide antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

In search of the Somogyi effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: Studies with somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Pathogenesis of Hypoglycemia in Insulinoma Patients: Suppression of Hepatic Glucose Production by Insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon").

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1991.260.2.E203

10.1152/AJPENDO.1991.260.2.E203

21 January 2018

Identifiers

DOI

0 references

1 reference